Drug General Information
Drug ID
D0BU5U
Former ID
DNC001143
Drug Name
PP2
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535940]
Structure
Download
2D MOL

3D MOL

Formula
C15H16ClN5
Canonical SMILES
CC(C)(C)N1C2=C(C(=N1)C3=CC=C(C=C3)Cl)C(=NC=N2)N
InChI
1S/C15H16ClN5/c1-15(2,3)21-14-11(13(17)18-8-19-14)12(20-21)9-4-6-10(16)7-5-9/h4-8H,1-3H3,(H2,17,18,19)
InChIKey
PBBRWFOVCUAONR-UHFFFAOYSA-N
CAS Number
CAS 37321-09-8
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Tyrosine-protein kinase 6 Target Info Inhibitor [535940]
WikiPathways EGF/EGFR Signaling Pathway
Focal Adhesion
References
Ref 535940Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res. 2004 Apr 1;10(7):2307-18.
Ref 535940Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res. 2004 Apr 1;10(7):2307-18.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.